{
    "pmcid": "9850341",
    "qa_pairs": {
        "How do nanobodies maintain efficacy against various SARS-CoV-2 variants?": [
            "Nanobodies bind conserved regions of the virus, helping to mitigate the impact of mutations.",
            "Nanobodies adapt their structure to fit new viral mutations, maintaining efficacy.",
            "Nanobodies increase their binding affinity in response to new variants.",
            "Nanobodies target the viral RNA, preventing replication regardless of mutations."
        ],
        "What are nanobodies and from where are they derived?": [
            "Nanobodies are small, monomeric antigen-binding fragments derived from the heavy chain-only antibodies found in camelids.",
            "Nanobodies are small, monomeric antigen-binding fragments derived from the light chain-only antibodies found in rodents.",
            "Nanobodies are large, dimeric antigen-binding fragments derived from the heavy chain-only antibodies found in humans.",
            "Nanobodies are large, multimeric antigen-binding fragments derived from the light chain-only antibodies found in birds."
        ],
        "What is a key advantage of nanobodies in therapeutic applications against SARS-CoV-2?": [
            "Nanobodies can be aerosolized and delivered via inhalation, allowing direct delivery to the lungs.",
            "Nanobodies can be administered orally, allowing for easy distribution and self-administration.",
            "Nanobodies can be injected intramuscularly, providing long-lasting systemic immunity.",
            "Nanobodies can be applied topically, offering localized treatment for skin manifestations."
        ],
        "What was a significant finding by Wagner et al. regarding nanobodies?": [
            "They developed a biparatopic nanobody (NM1267) with improved affinity and neutralization across different variants.",
            "They created a nanobody that could be administered orally with high efficacy.",
            "They engineered a nanobody that specifically targeted the viral RNA polymerase.",
            "They discovered a nanobody that could neutralize the virus by binding to the host cell receptor."
        ],
        "Which display technologies are used to select nanobodies from various libraries for SARS-CoV-2 diagnostics?": [
            "Phage, ribosome, and yeast surface display technologies are used.",
            "Phage, bacterial, and mammalian surface display technologies are used.",
            "Ribosome, bacterial, and insect surface display technologies are used.",
            "Yeast, mammalian, and plant surface display technologies are used."
        ]
    }
}